Research Library

Two new bills introduced in the Texas Legislature could jeopardize the care received by Medicaid patients, writes Vivian Ho, the James A. Baker III Institute Chair in Health Economics. She explains why the legislation would weaken county-owned insurance plans and raise Texans’ tax bills.

The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.

Gas stoves are a leading source of hazardous indoor air pollution, but they emit only a tiny share of the greenhouse gases that warm the climate. Why, then, have they assumed such a heated role in climate politics?

In 2022, the nation faced fundamental questions about how we govern our economy and society — particularly how we formulate public policy. Here, we share 10 highlights of our work that illustrate our impact from the previous year.

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

The 15% corporate minimum tax is one of the Inflation Reduction Act's key revenue-raising provisions Joyce Beebe reviews the background, operating mechanism and different perspectives associated with implementing the corporate minimum tax.

Introduction

The major drivers of Mexico’s outlook in 2022 will be 1) growing political polarization and social conflict…

This October the U.S. and Mexico agreed on a new bilateral security program, but "unless the United States and Mexico pursue domestic structural reforms ... both nations risk backsliding to the failures of the drug wars," writes MGA student and Drug Policy guest contributor Sidney Phillips.

"Perhaps surprisingly, the latest national data published by the U.S. Department of Labor suggest that the COVID-19 pandemic has not given small businesses greater cause for concern over the cost of health care benefits," writes McNair scholar Alisha Small. Read her post on the Baker Institute Blog.

To better reflect the iterative collaboration necessary for scientific progress, the Nobel Prize must expand its recognition to the many contributors of winning discoveries as well as diversify the selection committee, thereby also expanding recognition of the work of underrepresented minorities, argues this Baker Institute Blog post.